Author

Y.-K. Park

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

D. S. Schrump· 1 shared D. S. Singer· 1 shared H. Chen· 1 shared K. Ge· 1 shared L. Gesumaria· 1 shared T. G. Oliver· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

D. S. Schrump

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 Transactivation

H. Chen, L. Gesumaria, Y.-K. Park, T. G. Oliver, D. S. Singer, K. Ge, D. S. Schrump

This study identifies BET bromodomain proteins as coactivators of NEUROD1 in SCLC, showing that BET inhibitors suppress NEUROD1-target genes and reduce tumor growth.

bioRxiv · Oct 25, 2021Cancer Biology